SurePulse

Dr James Carpenter will present our new multi-parameter, wireless, vital sign monitoring for newborns to an audience of 90+ investors, strategics, clinicians, and industry leaders helping shape the future of medtech. #MedTechInnovator #MTIRadarForum

Excited to share that SurePulse Medical has been selected to pitch at the MedTech Innovator Virtual Radar Event on the 26th of March! We’re proud to be in the top 10% of over 1,800 applicants invited to compete for a spot in the MedTech Innovator Accelerator.

Great to be at the #DresdenSymposium discussing the latest research to improve care for newborns. Fantastic to see Prof Don Sharkey sharing our progress on next-generation vital sign monitoring in the delivery room to support clinical teams in those critical first moments.

@MedilinkMids The study uses simulation to evaluate technologies designed to improve monitoring of newborn babies during critical moments of care. 🔎 Read the full case study: buff.ly/UpsLObS #NeonatalCare #MedTechInnovation #Simulation #HealthInnovation #MeTAP #Medilink

@MedilinkMids has spotlighted SurePulse’s simulation study in a new case study exploring how MeTAP programme support is helping advance neonatal monitoring innovation.

Learn more: buff.ly/3VuaVVi #FamilyIntegratedCare #SkinToSkin #WirelessMonitoring #SurePulseVS #NeonatalInnovation

Promoting family-integrated care is essential for exceptional neonatal practice. SurePulse wireless vital sign monitoring enables better skin-to-skin bonding, letting parents cuddle and care for their baby after birth while ensuring continuous monitoring.

Dr Anne Maire Heuchan, Consultant Neonatologist at Glasgow Children’s Hospital discusses the challenges of monitoring heart rate at birth. Find out more about our wireless heart rate monitoring solutions for the delivery room: buff.ly/0hBds9J #Neonatology

We’re looking forward to attending the 17th Dresden Symposium 🗓 March 12–13 📍 Dresden, Germany The symposium is a key platform for intensive discussion around Delivery Room Management and the latest developments in neonatology. See you there!

Researchers in California report that ≥30 seconds of deferred cord clamping (DCC) is associated with a 24 g higher first-recorded weight in very preterm infants (<32 weeks). Read more: buff.ly/iJDHluO #Neonatology #NICU #PretermInfants #ClinicalResearch

10% of newborns (380K/year in the U.S.) need stabilization at birth. A heart rate <100 bpm for 2+ mins raises the risk of death 5x. (Kapadia) The SurePulse VS wireless cap provides quick, accurate heart rate data, because every second matters. #NeonatalCare #SurePulseVS

This means: ✅ Real-time vital sign monitoring while the cord remains intact ✅ Supporting clinical decision-making without premature cord clamping Read our article on the latest Optimal Cord Clamping Guidelines buff.ly/3XgHO8M #optimalcordclamping #delayedcordclamping

With SurePulse wireless vital sign monitoring, we can provide provide clinical teams with accurate, reliable, and timely information in the critical moments after birth.

Optimal cord clamping (OCC) offers vital benefits for newborns; improved oxygenation, higher iron stores, and better cardiovascular stability. Yet, in critical moments, ensuring a baby’s well-being while keeping the cord intact can be challenging.

Why it matters: DCC is already a vital part of preterm care, but many babies still suffer from low oxygen levels. This study shows that higher concentration oxygen provision during DCC could offer safer transitions for pre-term infants.

Read the full article here: buff.ly/5QoBlwJ #NeonatalCare #PretermBabies #DelayedCordClamping #SurePulse #NICU #MedicalInnovation

New Study Shows 100% Oxygen During Delayed Cord (DCC) Clamping May Improve Preemie Outcomes A new California study has found that giving 100% oxygen to extremely preterm babies during DCC significantly reduces the risk of early hypoxemia, without increasing harm.